Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis

Fig. 1

Forest plot of the adjusted relative risk of variables on duration of MODS in the total cohort (a) and the subjects with septic shock (b). In both the total cohort and septic shock subset, subjects with immunoparalysis had a higher risk of a greater duration of MODS when receiving hydrocortisone treatment (aRR 3.72 [1.76, 7.87] and aRR 4.57 [2.31, 9.07], respectively)

Back to article page